baber/WOPTO huggingface dataset:
Patent RU-2163734-C2 (RU)
Title: Image processing device and peripheral memory
Inventor: MASAKHIRO OTAKI
IPC: A63F13/52
Filed: 1991-11-15
Granted: 2001-02-27
Abstract: FIELD: image processing; television games. SUBSTANCE: device enabling display of multiple-image structures including transparent objects has image data generating facility for motionless images, image data generating facility for images other than motionless ones, and video signal generating facility. Novelty is introduction of limit data generating facility for generating data on position of right-hand boundary of window and data on position of left-hand boundary of window, data position changing facilities made for arbitrarily shaping window on screen, arithmetic operation facilities, facilities defining arithmetic operation function; video signal generating facility is designed to convert color data coming from arithmetic operation facility into video signal. EFFECT: reduced cost of device. 9 cl, 22 dwg, 1 tbl
Patent DE-10045133-C2 (DE)
Inventor: SIMPSON SHELL S
IPC: G06F3/12
Filed: 2000-09-13
Granted: 2003-10-02
Abstract: A computer implemented method by which a user edits and delivers a print job in a computer system, the method including providing a printing software object as a COM component for editing and delivering a print job and providing job data of the print job to the printing software object, by a print job creator, in the form of references to pages. The references to pages are used by the software printing object, to call and display the pages on a need basis. The user edits the job data of the print job based on the displayed pages and the print job is delivered for processing in accordance with the edited job data.
Patent DE-19800448-C2 (DE)
Inventor: UNGEMACH PETER
IPC: G08B26/00
Filed: 1998-01-08
Granted: 2000-04-27
Abstract: The system has at least one processor, a data memory containing. at least one processing program and an application library and addressable components with identifiable functions connected to the processor via a data communications path. The configuration method involves the following steps triggered by the processing program: setting the system into configuration mode; determining the functions and components; comparing them with the applications library; installing at least one application from the library with the determined components and functions and then setting the system into operating mode. An Independent claim is also included for a method of configuring the system.
Patent DE-19815429-C2 (DE)
Title: Verfahren zur regional abhängigen Vergebührung von Mobilfunk-Dienstleistungen
Inventor: BARTZ VOM FELD KLAUS
IPC: H04W4/02
Filed: 1998-04-07
Granted: 2001-03-22
Abstract: Beschrieben wird ein Verfahren zur regional abhängigen Vergebührung von Mobilfunk-Dienstleistungen in Mobilfunknetzen mit Teilnehmerendgeräten, wobei im Mobilfunk-Netzgebiet für den Mobilfunknutzer individuell für ihn gültige Aufenthaltsregionen definiert werden können, eine netzseitige Kontrolleinrichtung eine Mindestgröße dieser Aufenthaltsregionen sicherstellt, zu vergebührende Verbindungen entsprechend der momentanen Aufenthaltsregion des Mobilfunknutzers durch setzen von Parametern in den Verbindungsdaten gekennzeichnet werden und durch Vergleich mit vordefinierten regionalen Vergebührungsinformationen regional abhängige Vergebührungsdaten erstellt werden.
Patent MD-2915-C2 (MD)
Title: Plant for water flow power utilization
Inventor: POPUŞOI Leonid
IPC: F03B7/00
Filed: 2001-11-01
Abstract: The invention relates to the hydraulic power engineering and may be used in plants using the hydraulic flow power.The plant for water flow power utilization contains a floating turbine, placed horizontally, cinematically coupled with an electric generator 8 and joined with anchor elements, the blades 2 of which are submerged into the flow. Novelty consists in that the turbine is joined with the anchor elements by flexible rods (3) and includes a cylindrical body 1, onto which the blades 2 are fixed, at the same time the body 1 is joined with the electric generator 8, installed onto an abutment support by means of a cardan mechanism 5. The body 1 of the turbine may be made hollow.
Patent RU-2165704-C2 (RU)
Title: Method of preparing compound for killing insects or mites (variants), insecticide and antimite composition, method of killing insects or mite, strain saccharopolyspora spinosa used for preparing compound for insect and mite killing
Inventor: LOURENS KRIMER
IPC: A01N63/20
Filed: 1992-11-09
Granted: 2001-04-27
Abstract: FIELD: microbiology, insecticides. SUBSTANCE: invention relates to preparing novel insecticide agents by microbiological synthesis. Method of preparing the compound used for killing insects or mites involves culturing one of strains Saccharopolyspora spinosa NRRL 18719, NRRL 18720 or NRLL 18823 in suitable nutrient medium under submerged condition followed by isolation of individual compounds. Composition containing an active substance and a carrier is developed based on the compound obtained. Using the prepared compounds and compositions insects or mites are killed by treatment of their resident regions. EFFECT: improved method of preparing, new agents indicated above, enhanced effectiveness of compound. 16 cl, 13 tbl, 19 ex
Patent RU-2192831-C2 (RU)
Title: Absorbing structure, hygienic layer, disposable integral absorbing article
Inventor: BRISEBOJS GENRI
IPC: A61F5/44
Filed: 1996-12-13
Granted: 2002-11-20
Abstract: FIELD: private hygiene products. SUBSTANCE: absorbing article such as hygienic layer has liquid absorbing layer facing user's body and hydraulically adaptable component facing clothing and adapted for continuous and simultaneous adjustment of liquid absorbing layer on user's body in response to pressure. Upon application of pressure to surface of hydraulically adaptable component liquid volume of first part is movable to second part of said component for causing surface of second part of said component to swell up or bulge. Hydraulically adaptable component is made impermeable for liquid and adjoins liquid absorbing layer upon coming into dynamically sensible contact with said layer. Article is made resilient and capable of resisting to collapse and deformation. EFFECT: simplified structure and improved adaptation to user's body. 18 cl, 7 dwg
Patent RU-2197992-C2 (RU)
Inventor: SEDLACHEK KHANS-KHARAL D
IPC: C12N/
Filed: 1995-08-25
Granted: 2003-02-10
Abstract: FIELD: medicine. SUBSTANCE: method involves applying DNA structure which essential element is activating sequence, proportion modulus and active substance gene. The activating sequence is excited in cell- specific way in smooth muscle cells, activated endothelium cells, activated macrophages or activated lymphocytes. This activation process is cell cycle-specifically controlled by promotion modulus. The active substance is a smooth muscle cells growth inhibitor and/or blood coagulation inhibitor. The described DNA- sequence is inserted into virus or non-virus vector completed with a ligand agent possessing affinity to target cell. EFFECT: enhanced effectiveness of treatment. 34 cl, 11 dwg
Patent RU-2157807-C2 (RU)
Inventor: EMONDS-ALT XAVIER
IPC: A61P25/28
Filed: 1996-01-30
Granted: 2000-10-20
Abstract: FIELD: organic chemistry, heterocyclic compounds, pharmacy. SUBSTANCE: invention describes the novel substituted heterocyclic compounds of the formula (I)   where A means bivalent radical taken among -O-CO-, -CH 2 -O-CO- and others as indicated in p. 1 of the invention claim; R 1  means hydrogen atom or C 1 -C 4 -alkyl; m = 2, 3; Ar 1  means phenyl possibly substituted with halogen atom, hydroxyl group, C 1 -C 4 -alkoxy-group, C 1 -C 4 -alkyl, trifluoromethyl group, methylenedihydroxy-group; T means -CH 2 -Z, -CH(C 6 H 5 ) 2 , -C(C 6 H 5 ) 3 . Compounds of the formula (I) have affinity to tachikinin receptors, their inhibitory constant K i  is below 10 -8  M. Invention describes methods of synthesis of compounds of the formula (I) and intermediate compounds used. Invention describes also the pharmaceutical composition showing antagonistic activity to neurokinin receptors and containing compound of the formula (I) as an active component. EFFECT: new compounds indicated above, improved method of synthesis, valuable pharmacological properties. 25 cl, 3 tbl, 78 ex
Patent RU-2159600-C2 (RU)
Inventor: KISELEV A V
IPC: A61F9/008
Filed: 1998-04-17
Granted: 2000-11-27
Abstract: FIELD: medicine. SUBSTANCE: method involves carrying out vitrectomy. Perfluororganic substances are administered. Retinal cyst is opened in radial direction with respect to foveal area. Retinal laser coagulation is carried out on the boundary of the macular area. Argon laser radiation of 532 nm wavelength, 0.5-0.7 W power and 0.2-0.5 s duration is applied. The perfluororganic substances are removed in 2-3 weeks. EFFECT: enhanced effectiveness in removing cystic changes and macular area edema; improved vision function.
Patent RU-2167160-C2 (RU)
Inventor: JEGHAM SAMIR
IPC: C07D413/04
Filed: 1996-11-05
Granted: 2001-05-20
Abstract: FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to derivatives of 5-phenyl-3-(piperidine-4-yl)-1,3,4-oxadiazole- -2(3H)-one of the general formula (I)   where R 1  means the group (C 1 -C 4 )-alkyl or (C 3 -C 7 )-cycloalkylmethyl; X 1  means hydrogen or halogen atom or (C 1 -C 4 )-alkoxy-group or OR 1  and X 1  in common mean the group of the formula -OCH 2 O-, -O(CH 2 ) 2 -, -O(CH 2 ) 2 O- or -O(CH 2 ) 3 O-; X 2  means hydrogen atom or amino-group; X 3  means hydrogen or halogen atom and R 2  means hydrogen atom or possibly substituted group (C 1 -C 6 )-alkyl, or the group phenyl-(C 1 C 4 )-alkyl that can be substituted with phenyl ring, or the group phenyl-(C 2 -C 3 )-alkenyl, or the group phenoxy-(C 2 C 4 )-alkyl, or the group cyclo-(C 3 -C 7 )-alkylmethyl, or the group 2,3-dihydro-1H-indene-1-yl, or the group 2,3-dihydro-1H- -indene-2-yl, or the group of the general formula -(CH 2 ) n -CO-Z where n = 1-6 and Z means the group piperidine-1-yl or 4-(dimethylamino)-piperidine-1-yl. Indicated compounds can be used for treatment and prophylaxis of disorders with implication of receptors 5-HT 4  and/or H 3 , especially in the central nervous system, gastroenteric tract, lower urogenital organs or cardiovascular system. Invention describes method of synthesis of indicated compounds, pharmaceutical composition and drug also. EFFECT: improved method of synthesis, valuable medicinal and pharmacological properties. 7 cl, 1 tbl, 18 ex
Patent RU-2198821-C2 (RU)
Title: Method of control of auxiliary ship and auxiliary ship for realization of this method
Inventor: SALMI PEKKA
IPC: B63B35/08
Filed: 1998-07-30
Granted: 2003-02-20
Abstract: FIELD: method of control of auxiliary ship operating at open sea and in ice. SUBSTANCE: when ship operates during navigational period at sea free from ice, steering nozzle is fitted which is removed when ship operates in ice during navigational period. During operation of ship both with and without steering nozzle, continuous absorption of power by propulsor is maintained. Auxiliary ship is equipped with fasteners for mounting and dismantling the steering nozzle. EFFECT: enhanced efficiency. 9 cl, 9 dwg
Patent RU-2210354-C2 (RU)
Title: Nail polish
Inventor: BON MANFRED
IPC: A61K9/70
Filed: 1998-08-20
Granted: 2003-08-20
Abstract: FIELD: medicine, dermatology. SUBSTANCE; invention relates to polish eliciting antipsoriatic activity. The nail polish comprises an active substance, physiologically acceptable solvent and water-insoluble film-forming agent. Polish comprises at least one glucocorticoid as an active substance. The nail polish can be used for treatment of nails psoriasis, it provides good penetration and excludes the relapse disease of nails. EFFECT: enhanced effectiveness of polish. 6 cl, 5 ex
Patent RU-2252754-C2 (RU)
Title: Применение карипорида для уменьшения нежелательных воздействий макролидных антибиотиков при ишемии и реперфузии сердца
Inventor: LANG KHANS JOKHEN
IPC: A61K31/165
Filed: 1998-09-03
Granted: 2005-05-27
Abstract: Изобретение относится к медицине, в частности к кардиологии, и касается уменьшения побочных эффектов лекарственного средства с кардиотоксическим компонентом. Для этого предлагается использовать карипорид для уменьшения нежелательных воздействий макролидного антибиотика, в частности рулида. Изобретение обеспечивает возможность устранения побочных эффектов макролидного антибиотика в отношении сердца в условиях его ишемии и реперфузии. 2 табл.
Patent RU-2201309-C2 (RU)
Title: Method and apparatus for making corrugated sheet with microstructure passing across corrugations
Inventor: BRUECK ROLF
IPC: F01N3/28
Filed: 1997-08-14
Granted: 2003-03-27
Abstract: FIELD: manufacture of sheets used in catalytic converters, heat exchangers and so on. SUBSTANCE: apparatus includes attachment for forming microstructures and pairs of mutually engaged rolls for rolling corrugated sheet. Pairs of rolls are arranged behind said attachment. On outer surfaces of rolls there are sufficiently large recesses for microstructures preventing the last from deformation by rolls at corrugating metallic sheet. Method comprises steps of corrugating sheet by means of first pair of rolls; orienting roll recesses in accordance with microstructure position in such a way that to prevent smoothing of microstructures of corrugated sheet. EFFECT: enhanced quality of corrugated metallic sheet. 10 cl, 2 dwg
Patent RU-2166847-C2 (RU)
Title: Method for mutagenic treatment of cereal crop seeds
Inventor: DUDIN G P
IPC: C12N15/01
Filed: 1999-07-12
Granted: 2001-05-20
Abstract: FIELD: genetics and selection. SUBSTANCE: method involves wetting seeds of farm crops in urea aqueous solution with concentration of 0.03-2M for 8 h. Method allows yield of selection valuable morphological and physiological mutations of plants in second generation to be increased upon treatment with urea. EFFECT: increased efficiency and simplified method. 6 tbl
Patent UA-56269-C2 (UA)
Title: A process for preparing derivatives of thiazoleidyndione
IPC: C07D417/06
Filed: 1998-10-27
Abstract: A process for preparing a compound of formula (I) or a tautomeric form thereof or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, wherein: A1 represents a substituted or unsubstituted aromatic heterocyclyl group; R1 represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; A2 represents a benzene ring having in total up to five substituents; and n represents an integer in the range of from 2 to 6, which process comprises catalytically reducing a compound of formula (II): wherein A1, R1, A2 and n are as defined in relation to formula (I), characterised in that the reduction reaction is carried out using a hydrogen pressure above 20psi; and thereafter if required forming a pharmaceutically acceptable salt and/or a pharmaceutically acceptable solvate of the compound of formula (I). (I) (II)
Patent UA-27769-C2 (UA)
Title: Device and method for acceptance of digital signal in multiplex access system with hourly division
IPC: H04W56/00
Filed: 1992-08-19
Abstract: The invention relates to a method and a device for refreshing a time-controlled signal using multiple sample points. The proposed solution is to provide refreshing accepted symbols in the protocol packet to have been transmitted in presence generated by distortion channel
Patent UA-23019-C2 (UA)
Title: Method for frequency demodulation
Filed: 1993-10-21
Abstract: The method for frequency demodulation provides a demodulation signal delay. The pickup and delayed signals are phase-demodulated relative to each other. The invention relates to radio engineering and communication.
Patent UA-19371-C2 (UA)
Title: Method for explosion protection in operating systems for transportation of gases and dust and gas mixtures
IPC: A62C4/02
Filed: 1993-03-23
Abstract: A method for explosion protection in operating the systems for transportation of gases and dust and gas mixtures provides for the transfer of the gases and dust and gas mixtures through the catalytically active flame-arresting packing with the heat-exchanger. The cooling heat carrier is used when the temperature of packing gets equal to the operating temperature of the catalyst. When the temperature of the packing does not exceed the initial temperature required for the catalyst, the supply of the heat carrier is interrupted. When the flame is generated, the packings are heated to the initial temperature required for the activity of the catalyst.
Patent UA-10900-C2 (UA)
Title: Installation for gluing of labels, tags, excise stamps on packing
Filed: 1995-11-13
Abstract: The invention relates to the devices for labeling and can be used for gluing of labels, tags, excise stamps on packing. An installation contains a drive and an accumulator of labels, a mechanism for putting the glue on the label and a pasting mechanism installed on the rack.
Patent UA-50728-C2 (UA)
Title: Method for immunostimulation with lysozyme dimer
IPC: A61K38/47
Filed: 1996-01-13
Abstract: The present invention relates to pharmaceutical compositions containing a lysozyme dimer, preferably of high purity, i.e. with about 10 wt% or less of unintended by products, and new applications thereof. Such applications include topical, oral and parenteral administration of said compositions for nonspecific immunostimulation as a measure of prevention and/or therapeutic treatment of human and animals diseases comprising cancer, hair growth disorders, fish diseases and bee diseases. The nonspecific stimulation of the Immune system is induced by a single or repeated application of the lysozyme dimer composition, preferably at concentrations of 5 to 500 ag/kg body weight.
Patent UA-30078-C2 (UA)
Title: DamasK steel and method for producing the same
Inventor: Nazarenko Vasyl Romanovych
Filed: 1997-12-17
Abstract: The invention relates to the field of metallurgy, in particular to production of steel and can be used in many fields of industry for making impact-punching and cutting tool, accessory and structural pieces of machines, and also cold arms (sabres,dirks, swords, knives and other articles of artistic and decorative purpose). Damask steel contains carbon, silicon, manganese, aluminium, cerium and iron, at that it contains in addition boron and microalloying additives.
Patent UA-39812-C2 (UA)
Inventor: BUHAIENKO BORYS ANDRIIOVYCH
Filed: 1999-05-14
Abstract: A unit for rescue from high-rising engineering constructions has a rescue means and a one-pendant lowering-lifting device with an appliance for fixation with the disconnection mechanism of automated hook release and a unit of the rescue facility holding, at that the body of the rescue mean is rigidly connected through a disconnection unit to a frame structure, on which wings are installed, for instance, like a hang-glider wings, arranged in several horizons. The problem of decreasing the impact load at the rescue means coming down on the water, and of increasing the distance from the damaged construction to the place of the rescue means coming down on the water.
Patent UA-51310-C2 (UA)
Title: Separator for mineral mixes
Inventor: MOSTYKA YURII SERHIIOVYCH
IPC: B03C1/10
Filed: 2002-02-19
Abstract: Invention relates to the dressing of minerals. The separator of mineral mixtures contains a ferromagnetic roller located between magnetic poles of the source of magnetic field, which are closed by the yoke located on the basis, and a feeder. According to the invention, the yoke is mounted on the basis with possibility of displacement in the vertical plane and its fixation in assigned position. Invention provides for improvement of the quality of beneficiated raw material.
Patent RU-2204833-C2 (RU)
Inventor: MEDVINSKIJ I D
IPC: G01N33/49
Filed: 2000-03-17
Granted: 2003-05-20
Abstract: FIELD: medicine, obstetrics. SUBSTANCE: in the first trimester of pregnancy on should study the quantity of free endotheliocytes, level of D-dimers, fibrinogen, the number of thrombocytes and that of type III lymphocytes, the level of interleukin-6, index of leukocytic activity, total peripheral vascular resistance (TPVR), based upon these values one should calculate F value by the formula, at F above 0 it is possible to conclude that pregnant woman potentially belongs to risk group for POF development, at F under 0 - that pregnant woman belongs to the group where POF won't be developed during pregnancy course. The method enables to detect patients belonging to risk group for POF development earlier and prescribe corresponding therapy. EFFECT: higher efficiency of prediction. 2 ex
Patent RU-2185103-C2 (RU)
Inventor: LOSHCHENOV V B
IPC: G01N33/48
Filed: 2000-03-29
Granted: 2002-07-20
Abstract: FIELD: medicine. SUBSTANCE: method involves putting biological culturing medium containing tumor cell culture into transparent reservoir for carrying out photobiological studies. Photosensibilization agent is added. The cell culture is incubated with the photosensibilization agent and then washed out from the photosensibilized culturing medium. Clean culturing medium is added. Erythrocytes are additionally introduced into the culturing medium immediately before irradiation. The so created medium is irradiated. Medium absorption or scattering spectrum is read during irradiation procedure in optical bandwidth. Medium oxygenation degree and its variation rate are determined from the relation between oxy- and desoxyhemoglobin contributions into the spectrum and photodynamic photosensibilization agent activity is determined in this way with respect to ratio of medium oxygenation variation speed to irradiation power density. Erythrocytes are introduced in the amount of 0.2-1 % by volume. EFFECT: enhanced reliability and simplicity of the method. 2 cl
Patent RU-2212212-C2 (RU)
Inventor: KANJUKOV V N
IPC: A61F9/007
Filed: 2000-04-24
Granted: 2003-09-20
Abstract: FIELD: medicine. SUBSTANCE: method involves making conjunctival incision. Muscle the action of which is planned to be reduced, is exposed. Recession place is marked on sclera on both sides of the muscle. Scleral suture is made on the place of one of the sclera marks. The it is continued over the muscle in catching 1/3-1/4 of muscle tendon from top and down. Scleral suture is put in once more on the second sclera mark place. The muscle is transected. The thread is stretched. The suture is bound with three knots. The thread is cut. Incision in conjunctiva is done on the other side. A muscle the action of which is planned to be increased, is exposed. Place of cut is marked on sclera on both sides. A suture is stitched in succession over sclera, muscle tendon in catching 1/3-1/4 of muscle tendon and on the side over sclera according to the mark. The muscle tendon is transected near the place it is attached to sclera. The thread is pulled. The thread is stretched. The suture is bound with three knots. The thread is cut. EFFECT: enhanced effectiveness of treatment; simplified method; accelerated surgical intervention. 2 dwg